Zobrazeno 1 - 1
of 1
pro vyhledávání: '"Shiori Noomote"'
Autor:
Tae Hatsuyama, Osamu Honjo, Takayuki Toda, Shiori Noomote, Keisuke Gto, Hideki Sato, Kengo Umehara, Yasuka Okazaki, Azusa Wakamoto, Yuki Okayama
Publikováno v:
Annals of Oncology. 30:vi140-vi141
Background Since osimertinib significantly prolonged progression free survival compared with conventional EGFR-TKI and was well-tolerated, it was approved in August 2018 as the primary treatment in EGFR mutation positive non-small cell lung cancer. I
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::25d3e15f4d04ce8fb9b85b18c3173b54
https://doi.org/10.1093/annonc/mdz343.107
https://doi.org/10.1093/annonc/mdz343.107
